The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders an open, uncontrolled, multicentre study
We assessed the efficacy and safety of the new, long-acting dopamine agonist drug cabergoline during long-term therapy of hyperprolactinaemia. Open, prospective, multicentre study. One hundred and sixty-two females with either a microprolactinoma (n =loo), idiopathic hyperprolactinaemia (n = 54), e...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Wiley
1993
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | http://eprints.um.edu.my/10455/1/The_efficacy_and_tolerability_of_long-term.pdf |